29 Oct The Risk Benefit Analysis of Mesenchymal Stem Cell Therapy
Posted at 17:51h
in Amniotic Stem Cells, Regenerative Medicine, stem cell therapy, Umbilical Cord Stem Cells
0 Comments
Over the past eight years, R3 Stem Cells’ Centers of Excellence in the US, Mexico and Pakistan have administered over [procedure_value] stem cell and exosome procedures. With eight years of experience and over 15 IRB Approved protocols, R3 Stem Cell’s Centers are trusted by patients...